Notch信号转录抑制DMT1调节细胞内铁代谢参与血管壁细胞表型转换及肿瘤血管正常化的机制研究
批准号:
82103446
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张信信
依托单位:
学科分类:
肿瘤微环境
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张信信
中文摘要
肿瘤血管结构功能的紊乱促进肿瘤恶性进展,血管壁细胞表型可塑性引起的壁细胞功能失常是血管异常的关键因素,然而,调控肿瘤壁细胞表型转换的分子机制尚不明确。申请人前期研究表明,肿瘤微环境壁细胞中Notch信号处于抑制状态,活化Notch信号可促进壁细胞收缩蛋白的表达,抑制其炎性分泌表型,促进肿瘤血管正常化,抑制肿瘤进展,并伴随铁代谢相关通路的抑制、关键转运分子DMT-1表达的下降,和细胞内铁含量的降低。预实验结果表明,铁过载可消除Notch信号介导的壁细胞表型调控效应。因此,Notch信号可能通过降低细胞内铁含量调控壁细胞表型转化过程,促进血管正常化。本课题拟进一步明确Notch信号通过DMT-1调控细胞内铁稳态的作用和机制,阐明细胞内铁在壁细胞表型转换中的细胞生物学功能,揭示“Notch信号-铁代谢”调控的壁细胞表型转化在肿瘤血管正常化及肿瘤进展中的意义,为肿瘤血管正常化治疗策略提供新的靶点。
英文摘要
The disorder of tumor vascular structure and function promotes the malignant progression of tumor. Vascular mural cell dysfunction caused by vascular mural cell phenotypic plasticity is the key factor of vascular abnormalities. However, the molecular mechanism of regulating tumor mural cell phenotypic transformation remains unclear. Our previous studies have indicated that Notch signaling in tumor microenvironment mural cells is inhibited. Activation of Notch signaling can promote the expression of contractile proteins in mural cells, inhibit their inflammatory secretion phenotype, promote the normalization of tumor vessels, inhibit tumor progression, and accompany with the inhibition of iron metabolism-related pathways and the decrease of the expression of DMT-1, a key transport molecule of iron metabolism. The results of the pre-experiment showed that iron overload could eliminate the effect of Notch signaling on the regulation of mural cell phenotype. Therefore, Notch signaling may regulate the phenotypic transformation of mural cells and promote vessel normalization by reducing intracellular iron content. This project aims to further clarify the role and mechanism of Notch signaling in regulating intracellular iron homeostasis through DMT-1, clarify the cellular biological function of intracellular iron in mural cell phenotypic transformation, and reveal the significance of "Notch signaling-iron metabolism"-regulated mural cell phenotypic transformation in tumor vessel normalization and tumor progression, so as to provide a new therapeutic target for the treatment strategy of tumor vessel normalization.
肿瘤血管结构功能的紊乱促进肿瘤恶性进展,血管平滑肌细胞(VSMC)表型可塑性引起的平滑肌细胞功能失常是血管异常的关键因素,然而,调控平滑肌细胞表型转换的分子机制尚不明确。本课题组主要从以下内容展开:1. 在VMSC中活化Notch信号可促进血管平滑肌细胞收缩蛋白的表达,抑制其炎性分泌表型,促进肿瘤血管正常化,抑制肿瘤进展,通过转录组测序、实时定量PCR及western-blot等发现此过程伴随铁代谢相关通路的抑制、关键转运分子DMT-1等表达的下降,细胞内铁含量相应降低。进一步研究显示,Notch活化可通过下游转录因子HES1的表达抑制DMT-1的转录,HES1敲除阻断Notch活化对DMT-1表达的影响,体内实验表明,铁含量的变化参与Notch信号对血管平滑肌细胞表型及血管结构的调控作用,进而影响肿瘤的生长。2. 课题组前期研究提示Notch信号通过小干扰RNA参与血管内皮细胞活动和分化,在血管平滑肌细胞中进一步研究,发现Notch信号激活上调VSMCs中miR-342的表达,miR-342的过表达进一步诱导VSMCs的表型转换,阻断miR-342可以抑制VSMCs的表型转换,miR-342-5p过表达与Notch信号调控VSMC表型变化的作用相反,进一步研究提示miR-342-5p通过直接靶向FOXO3负反馈调节Notch信号通路,在VSMCs中阻断 miR-342 可下调细胞因子生成并抑制肿瘤生长。我们的研究揭示了Notch信号转录水平调控细胞内铁稳态的作用和机制,揭示“Notch信号-铁代谢”调控的表型转化在肿瘤血管正常化及肿瘤进展中的意义;阐明了Notch信号与小干扰RNA之间的负反馈调控作用机制及在vSMCs表型转换以及进一步在肿瘤进展中的作用,为肿瘤血管正常化治疗策略提供新的靶点,为后续研究奠定了基础。
国内基金
海外基金